Adherence to Atrial Fibrillation Better Care (ABC) Pathway Management of Chinese Community Elderly Patients with Atrial Fibrillation: A Cross-Sectional Study

References

• Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498. doi:10.1093/eurheartj/ehaa612
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen Z, Wang X, et al. The disease burden of atrial fibrillation in China from a national cross-sectional survey. Am J Cardiol. 2018;122(5):793–798. doi:10.1016/j.amjcard.2018.05.015
   PubMed Web of Science ®Google Scholar
• Cheng X, Zhou X, Song S, et al. Ethnicity and anticoagulation management of hospitalized patients with atrial fibrillation in northwest China. Sci Rep. 2017;7:45884. doi:10.1038/srep45884
   PubMed Web of Science ®Google Scholar
• Guo Y, Tian Y, Wang H, Si Q, Wang Y, Lip GYH. Prevalence, incidence, and lifetime risk of atrial fibrillation in China: new insights into the global burden of atrial fibrillation. Chest. 2015;147(1):109–119. doi:10.1378/chest.14-0321
   PubMed Web of Science ®Google Scholar
• Alobaida M, Alrumayh A. Rate control strategies for atrial fibrillation. Ann Med. 2021;53(1):682–692. doi:10.1080/07853890.2021.1930137
   PubMed Web of Science ®Google Scholar
• Romiti GF, Pastori D, Rivera-Caravaca JM, et al. Adherence to the ‘atrial fibrillation better care’ pathway in patients with atrial fibrillation: impact on clinical outcomes-A systematic review and meta-analysis of 285,000 Patients. Thromb Haemost. 2022;1222(3):406–414. doi:10.1055/a-1515-9630
   Google Scholar
• Salis F, Palimodde A, Demelasb G, Scionis MI, Mandas A. Frailty and comorbidity burden in Atrial Fibrillation. Front Public Health. 2023;11:1134453. doi:10.3389/fpubh.2023.1134453
   PubMed Web of Science ®Google Scholar
• Kotalczyk A, Guo Y, Stefil M, Wang Y, Lip GYH; ChiOTEAF Registry Investigators. Effects of the atrial fibrillation better care pathway on outcomes among clinically complex Chinese patients with atrial fibrillation with multimorbidity and polypharmacy: a report from the ChiOTEAF Registry. J Am Heart Assoc. 2022;11(7):e24319. doi:10.1161/JAHA.121.024319
   Web of Science ®Google Scholar
• Ye RF, Zhang ML, Deng WP, Ogrin R. Correlative analysis between received support, anticipated support and quality of life in retired elderly patients. Chin J Behav Med Sci. 2008;17:217–219.
   Google Scholar
• Green MM, Lowthian JA, Allgood H, et al. Volunteer peer support frameworks supporting older women living alone. Health Soc Care Community. 2022;30(6):e4252–e4263. doi:10.1111/hsc.13818
   PubMed Web of Science ®Google Scholar
• Wang YF, Jiang C, He L, et al. Integrated care of atrial fibrillation using the ABC (Atrial fibrillation Better Care) pathway improves clinical outcomes in Chinese population: an analysis from the Chinese Atrial Fibrillation Registry. Front Cardiovasc Med. 2021;8:762245. doi:10.3389/fcvm.2021.762245
   PubMed Web of Science ®Google Scholar
• Guo Y, Lane DA, Wang L, et al. Mobile health technology to improve care for patients with atrial fibrillation. J Am Coll Cardiol. 2020;75(13):1523–1534. doi:10.1016/j.jacc.2020.01.052
   PubMed Web of Science ®Google Scholar
• Shen AY, Yao JF, Brar SS, Jorgensen MB, Wang X. Racial/Ethnic differences in ischemic stroke rates and the efficacy of warfarin among patients with atrial fibrillation. Stroke. 2008;39(10):2736–2743. doi:10.1161/STROKEAHA.107.508580
   PubMed Web of Science ®Google Scholar
• Freedman B, Camm J, Calkins H, et al. Screening for atrial fibrillation a report of the AF-SCREEN international collaboration. Circulation. 2017;135(19):1851–1867. doi:10.1161/CIRCULATIONAHA.116.026693
   PubMed Web of Science ®Google Scholar
• Diederichs C, Berger K, Bartels DB. The measurement of multiple chronic diseases--a systematic review on existing multimorbidity indices. J Gerontol a Biol Sci Med Sci. 2011;66(3):301–311. doi:10.1093/gerona/glq208
   PubMed Web of Science ®Google Scholar
• Viktil KK, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol. 2007;63(2):187–195. doi:10.1111/j.1365-2125.2006.02744.x
   PubMed Web of Science ®Google Scholar
• Guo QH, Zhang YQ, Wang JG. Asian management of hypertension: current status, home blood pressure, and specific concerns in China. J Clin Hypertens. 2020;22(3):475–478. doi:10.1111/jch.13687
   PubMed Web of Science ®Google Scholar
• Beijing Association for Hypertension Prevention and Control, Beijing Association for Diabetes Prevention and Control, Beijing Association for Chronic Disease Prevention and Health Education, Hypertension Alliance (China), National Clinical Research Center for Geriatric Diseases, China Alliance for the Prevention and Treatment of Cardiovascular Disease in the Elderly. Practice guidelines (2020) for integrated management of cardiovascular diseases in primary hospitals. Chin J Front Med. 2020;12:1–73.
   Google Scholar
• Du X, Guo L, Xia S, et al. Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China. Heart. 2021;107(7):535–541. doi:10.1136/heartjnl-2020-317915
   PubMed Web of Science ®Google Scholar
• Ye S, Wang T, Liu A, Yu Y, Pan Z, Gu J. A study of knowledge, attitudes, and practices of primary care physicians toward anticoagulant therapy in patients with non-valvular atrial fibrillation in Shanghai, China. BMC Fam Pract. 2020;21(1):165. doi:10.1186/s12875-020-01236-4
   PubMed Web of Science ®Google Scholar
• Proietti M, Romiti GF, Olshansky B, Lane DA, Lip GYH. Improved outcomes by integrated care of anticoagulated patients with atrial fibrillation using the Simple ABC (Atrial Fibrillation Better Care) pathway. Am J Med. 2018;131(11):1359–1366.e6. doi:10.1016/j.amjmed.2018.06.012
   PubMed Web of Science ®Google Scholar
• Pastori D, Menichelli D, Violi F, Pignatelli P, Lip GYH; ATHERO-AF study group. The Atrial fibrillation Better Care (ABC) pathway and cardiac complications in atrial fibrillation: a potential sex-based difference. The ATHERO-AF study. Eur J Intern Med. 2021;85:80–85. doi:10.1016/j.ejim.2020.12.011
   PubMed Web of Science ®Google Scholar
• Wei Y, Xu J, Wu H, et al. Survey of antithrombotic treatment in rural patients (>60 years) with atrial fibrillation in East China. Sci Rep. 2018;8(1):6830. doi:10.1038/s41598-018-24878-y
   PubMed Web of Science ®Google Scholar
• Kozieł M, Teutsch C, Bayer V, et al. Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world. J Arrhythm. 2021;37(4):990–1006. doi:10.1002/joa3.12588
   PubMed Web of Science ®Google Scholar
• Wei H, Cui C, Cui X, Liu Y, Li D. Cost-effectiveness analysis of dabigatran, rivaroxaban and warfarin in the prevention of stroke in patients with atrial fibrillation in China. BMC Health Serv Res. 2021;21(1):96. doi:10.1186/s12913-021-06084-1
   PubMed Web of Science ®Google Scholar
• Yang PS, Sung JH, Jang E, et al. Application of the simple atrial fibrillation better care pathway for integrated care management in frail patients with atrial fibrillation: a nationwide cohort study. J Arrhythm. 2020;36(4):668–677. doi:10.1002/joa3.12364
   PubMed Web of Science ®Google Scholar
• Latchamsetty R, Morady F. Atrial fibrillation ablation. Annu Rev Med. 2018;69:53–63. doi:10.1146/annurev-med-041316-090015
   PubMed Web of Science ®Google Scholar
• Proietti M, Vitolo M, Lip G. Integrated care and outcomes in patients with atrial fibrillation and comorbidities. Eur J Clin Invest. 2021;51(6):e13498. doi:10.1111/eci.13498
   PubMed Web of Science ®Google Scholar
• Proietti M, Romiti GF, Olshansky B, Lane DA, Lip GYH. Comprehensive management with the ABC (Atrial Fibrillation Better Care) pathway in clinically complex patients with atrial fibrillation: a post hoc ancillary analysis from the AFFIRM trial. J Am Heart Assoc. 2020;9(10):e014932. doi:10.1161/JAHA.119.014932
   PubMed Web of Science ®Google Scholar
• Xing L, Jing L, Tian Y, et al. Epidemiology of dyslipidemia and associated cardiovascular risk factors in northeast China: a cross-sectional study. Nutr Metab Cardiovasc Dis. 2020;30(12):2262–2270. doi:10.1016/j.numecd.2020.07.032
   PubMed Web of Science ®Google Scholar
• Li F, Du X, He L, et al. Relationship between serum lipid levels and ischemic stroke in patients with atrial fibrillation: a nested case-control study based on the China Atrial Fibrillation Registry. BMC Cardiovasc Disord. 2021;21(1):424. doi:10.1186/s12872-021-02237-6
   PubMed Web of Science ®Google Scholar
• Gumprecht J, Domek M, Proietti M, et al. Compliance of atrial fibrillation treatment with the Atrial Fibrillation Better Care (ABC) pathway improves the clinical outcomes in the middle east population: a report from the gulf Survey of Atrial Fibrillation Events (SAFE) Registry. J Clin Med. 2020;9(5):1286. doi:10.3390/jcm9051286
   PubMed Web of Science ®Google Scholar